𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Iron-Overload–Related Disease in HFE Hereditary Hemochromatosis

✍ Scribed by Allen, Katrina J.; Gurrin, Lyle C.; Constantine, Clare C.; Osborne, Nicholas J.; Delatycki, Martin B.; Nicoll, Amanda J.; McLaren, Christine E.; Bahlo, Melanie; Nisselle, Amy E.; Vulpe, Chris D.; Anderson, Gregory J.; Southey, Melissa C.; Giles, Graham G.; English, Dallas R.; Hopper, John L.; Olynyk, John K.; Powell, Lawrie W.; Gertig, Dorota M.

Book ID
127083209
Publisher
Massachusetts Medical Society
Year
2008
Tongue
English
Weight
164 KB
Volume
358
Category
Article
ISSN
0096-6762

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase 1/2, dose-escalation trial of de
A phase 1/2, dose-escalation trial of deferasirox for the treatment of iron overload in HFE-related hereditary hemochromatosis
✍ Pradyumna Phatak; Pierre Brissot; Mark Wurster; Paul C Adams; Herbert L. Bonkovs 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 391 KB 👁 1 views

Hereditary hemochromatosis (HH) is characterized by increased intestinal iron absorption that may result in iron overload. Although phlebotomy is widely practiced, it is poorly tolerated or contraindicated in patients with anemias, severe heart disease, or poor venous access, and compliance can vary